Search - tctmd.com

Displaying 101 - 120 of 133

Sort: Relevancy | Date

Presentation TCT 2014

For the Proposal!

Presenter: Philip M. Meyers

September 14, 2014

Presentation TCT 2014

Appropriate Use Criteria in the Periphery: Status Update

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Sahil A. Parikh

September 14, 2014

Presentation TCT 2014

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Mark H. Wholey

September 14, 2014

Presentation TCT 2014

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Raghu Kolluri

September 14, 2014

Presentation TCT 2014

The BEST and BASIL 2 Studies: Designs and Goals

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Kenneth Rosenfield

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

Presentation TCT 2014

Pedal Access and Retrograde CTO Crossing: Tips and Tools from a Master

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Jihad A. Mustapha

September 14, 2014

Presentation TCT 2014

A Primer of the Pedal Circulation: Relevance to Revascularization Strategies

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Jihad A. Mustapha

September 14, 2014

Presentation TCT 2014

Is Arteriopathy Below the Knee Biologically Unique? Implications for Therapeutic Approaches

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Lanfroi Graziani

September 14, 2014

Presentation

Predictors of Nonhealing After Successful Endovascular Therapy in Patients with Critical Limb Ischemia and Tissue Loss

Presenter: Norihiro Kobayashi

August 28, 2014

Presentation Cell Therapy 2014

HGF for Critical Limb Ischemia

Presenter: Emerson C. Perin

January 22, 2014

Presentation TCT 2013

Vascular Intervention Highlights (from Aneurysms to Critical Limb Ischemia): Achievements, Challenges, and Future Directions

Presenter: Barry Katzen

October 31, 2013

Presentation TCT 2013

Case 2: Critical Limb Ischemia with a Six-Week Heel Ulcer (Medial and Lateral) in a 65-Year-Old Diabetic Male

Presenter: William Gray

October 28, 2013

Presentation

Long-term Outcomes Following Infrapopliteal Angioplasty for Critical Limb Ischemia

Presenter: R.C. Lo

February 13, 2013

Presentation TCT 2013

Optimal Antiplatelet Regimen for Critical Limb Ischemia due to Pure Isolated Infrapopliteal Lesions

Presenter: Junichi Tazaki, Keisuke Hirano, Osamu Iida, Daizo Kawasaki, Takeshi Kimura, Yusuke Miyashita, Yoshiaki Shintani, Yoshimitsu Soga, Nobuhiro Suematsu, Kenji Suzuki, Terutoshi Yamaoka, Yasutaka Yamauchi

January 31, 2013

Presentation TCT 2013

Long term effect of transcatheter intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia

Presenter: Jean-Claude Lubanda, Miroslav Chochola, Robert Pytlik, Ales Linhart

January 31, 2013

Presentation TCT 2013

Endovascular Intervention in Patients with Critical Limb Ischemia in Taiwan: Patient Outcomes in 333 Consecutive Limb Procedures with a 6-year Follow-up

Presenter: Hsuan Li Huang

January 31, 2013

Presentation Cell Therapy 2013

SDF-1 Plasmid for Treatment of Critical Limb Ischemia

Presenter: David Paul Slovut

January 22, 2013

Presentation

A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia

Presenter: Douglas W. Losordo

December 02, 2012

Presentation AHA 2012

Endovascular Treatment for Infrainguinal Vessels in Patients with Critical Limb Ischemia: OLIVE Registry, a Prospective, Multicenter Study in Japan with 12-month Follow-up

Presenter: Masato Nakamura

November 06, 2012

Advertisement

For the Proposal!

Appropriate Use Criteria in the Periphery: Status Update

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

The BEST and BASIL 2 Studies: Designs and Goals

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Pedal Access and Retrograde CTO Crossing: Tips and Tools from a Master

A Primer of the Pedal Circulation: Relevance to Revascularization Strategies

Is Arteriopathy Below the Knee Biologically Unique? Implications for Therapeutic Approaches

Predictors of Nonhealing After Successful Endovascular Therapy in Patients with Critical Limb Ischemia and Tissue Loss

HGF for Critical Limb Ischemia

Vascular Intervention Highlights (from Aneurysms to Critical Limb Ischemia): Achievements, Challenges, and Future Directions

Case 2: Critical Limb Ischemia with a Six-Week Heel Ulcer (Medial and Lateral) in a 65-Year-Old Diabetic Male

Long-term Outcomes Following Infrapopliteal Angioplasty for Critical Limb Ischemia

Optimal Antiplatelet Regimen for Critical Limb Ischemia due to Pure Isolated Infrapopliteal Lesions

Long term effect of transcatheter intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia

Endovascular Intervention in Patients with Critical Limb Ischemia in Taiwan: Patient Outcomes in 333 Consecutive Limb Procedures with a 6-year Follow-up

SDF-1 Plasmid for Treatment of Critical Limb Ischemia

A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia

Endovascular Treatment for Infrainguinal Vessels in Patients with Critical Limb Ischemia: OLIVE Registry, a Prospective, Multicenter Study in Japan with 12-month Follow-up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content